Skip to main content
Improve Medical Instruments CO., Ltd. logo

Improve Medical Instruments CO., Ltd. — Investor Relations & Filings

Ticker · 300030 ISIN · CNE100000JL3 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,954 across all filing types
Latest filing 2023-11-10 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 300030

About Improve Medical Instruments CO., Ltd.

https://www.improve-medical.com

Improve Medical Instruments CO., Ltd. focuses on the development, production, and distribution of clinical laboratory and nursing solutions. The core product range includes evacuated blood collection systems, specimen collection and transport media, and laboratory automation equipment. The company also provides medical imaging components and point-of-care testing (POCT) systems. By integrating research and development with advanced manufacturing, the organization supports clinical diagnostics and patient care through high-precision tools designed for healthcare facilities and research laboratories. Its offerings are characterized by a commitment to diagnostic safety and efficiency across global markets.

Recent filings

Filing Released Lang Actions
关于独立董事取得独立董事资格证书的公告
Board/Management Information Classification · 95% confidence The document is a short announcement regarding the qualification certificate obtained by an independent director of the company. It mentions board meetings and shareholder meetings related to the election of the independent director, and the receipt of the independent director qualification certificate as per Shenzhen Stock Exchange regulations. The document is brief (576 characters) and does not contain financial data, financial statements, or detailed management discussion. It is an announcement about a board/management related event, specifically about the independent director's qualification status. Therefore, it fits best under Board/Management Information (MANG).
2023-11-10 Chinese
关于全资子公司变更医疗器械生产许可证及注册证的公告
Regulatory Filings Classification · 95% confidence The document is an official announcement from 阳普医疗科技股份有限公司 regarding changes to the medical device production license and registration certificate of its wholly-owned subsidiary. It details the change of production address and updates to registration information issued by the Guangdong Provincial Drug Administration. The document includes a risk warning about the impact of these changes on the company's operations. There are no financial statements, earnings data, or detailed financial analysis present. The document is a regulatory announcement about operational license changes, not a financial report or management discussion. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2023-10-27 Chinese
第六届监事会第五次会议决议公告
Regulatory Filings Classification · 95% confidence The document is a resolution announcement from the Supervisory Board of Yangpu Medical Technology Co., Ltd. regarding the approval of the company's 2023 third quarter report. It states that the Supervisory Board has reviewed and approved the 2023 third quarter report, confirming its accuracy and completeness. However, the document itself does not contain the actual financial data or the full report but refers to the report being available on the designated disclosure website. The document length is short (667 characters) and serves as an announcement of the approval of the interim report rather than the report itself. According to the 'Menu vs Meal' rule, this is not the interim report but an announcement related to it. Therefore, the appropriate classification is Regulatory Filings (RNS), as it is a regulatory announcement about the approval of a quarterly report without containing substantive financial data.
2023-10-26 Chinese
关于披露2023年第三季度报告的提示性公告
Report Publication Announcement Classification · 100% confidence The document is a short announcement (401 characters) indicating that the company has approved its 2023 third quarter report and that the full report will be disclosed on a specified website on a future date. It does not contain the actual financial data or the report itself, but rather serves as a notice to investors to check the full report elsewhere. According to the 'Menu vs Meal' rule, such a brief notice about the report's availability is classified as a Report Publication Announcement (RPA), not as the Interim/Quarterly Report (IR) itself.
2023-10-26 Chinese
第六届董事会第五次会议决议公告
Regulatory Filings Classification · 95% confidence The document is a formal announcement of the resolutions passed at the company's sixth board meeting, specifically approving the 2023 third quarter report. It states that the board has reviewed and approved the quarterly report, but the actual report is referenced as being available elsewhere (on the designated disclosure website). The document itself is short (654 characters) and serves as a notice of the board's approval rather than containing the full quarterly financial data or analysis. Therefore, it is not the Interim/Quarterly Report itself but an announcement related to it. Given the nature of the content, it fits best as a Regulatory Filing (RNS) because it is a formal disclosure about the board meeting and report approval without the full report included.
2023-10-26 Chinese
2023年三季度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled "阳普医疗科技股份有限公司2023 年第三季度报告" which translates to "Yangpu Medical Technology Co., Ltd. 2023 Third Quarter Report." It contains detailed financial data including income statement, balance sheet, cash flow statement, and explanations of financial performance for the third quarter of 2023. The document includes comprehensive financial metrics, accounting data, shareholder information, and notes on company activities during the quarter. It explicitly states it is a quarterly report and is unaudited. The length is substantial (15,000 characters), and it contains actual financial statements and analysis, not just an announcement or certification. Therefore, this document fits the definition of an Interim / Quarterly Report (IR). Q3 2023
2023-10-26 Chinese

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.